Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias

被引：7

作者：

Chim, C. S. ^{[1
]}

Chan, W. W. L. ^{[1
]}

Kwong, Y. L. ^{[1
]}

机构：

[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China

来源：

JOURNAL OF CLINICAL PATHOLOGY | 2008年 / 61卷 / 07期

关键词：

D O I：

10.1136/jcp.2007.047324

中图分类号：

R36 [病理学];

学科分类号：

100104 [病理学与病理生理学];

摘要：

Background: Dysregulation of apoptosis is important in carcinogenesis. Aim and Methods: To analyse the potential inactivation of the DAP kinase/p14/HDM2/p53/Apaf-1 pathway by aberrant promoter methylation in acute leukaemias. Results: Of five leukaemic lines examined, p14 was unmethylated in Raji, HL60 and U937, but completely deleted in Jurkat and NB4. DAP kinase was totally methylated in Raji and NB4, but unmethylated in HL60, Jurkat and U937. Apaf-1 was unmethylated in all the lines. At diagnosis, DAP kinase methylation occurred in eight (25%) APL patients and none of the other AML patients (8/32 vs 0/50, p = 0.001). DAP kinase methylation was detected in four (16%) ALL patients. p14 and Apaf-1 methylation was not detected in any of the 32 cases of acute promyelocytic leukaemia (APL), 50 cases of other subtypes of acute myeloid leukaemia (AML), and 25 cases of acute lymphoblastic leukaemia. Conclusion: Among AML subtypes, DAP kinase is preferentially hypermethylated in APL.

引用

页码：844 / 847

页数：4

共 38 条

[1]

Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia [J].

Au, WY ;

Lie, AKW ;

Chim, CS ;

Liang, R ;

Ma, SK ;

Chan, CH ;

Mak, YK ;

Chen, YT ;

So, CC ;

Yeung, YM ;

Yip, SF ;

Wong, LG ;

Chan, JC ;

Liu, SY ;

Kwong, YL .

ANNALS OF ONCOLOGY, 2003, 14 (05) :752-757

[2]

Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide [J].

Au, WY ;

Chim, CS ;

Lie, AKW ;

Liang, R ;

Kwong, YL .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) :130-132

[3]

PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[4]

Chan EC, 2002, CLIN CANCER RES, V8, P3741

[5]

Hypermethylation of gene promoters in hematological neoplasia [J].

Chim, CS ;

Liang, R ;

Kwong, YL .

HEMATOLOGICAL ONCOLOGY, 2002, 20 (04) :167-176

[6]

Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor [J].

Chim, CS ;

Chan, WWL ;

Pang, A ;

Kwong, YL .

LEUKEMIA, 2006, 20 (05) :907-909

[7]

CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia [J].

Chim, CS ;

Lau, JS ;

Wong, KF ;

Kwong, YL .

LEUKEMIA, 2006, 20 (01) :149-151

[8]

Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia [J].

Chim, CS ;

Wong, SY ;

Pang, A ;

Chu, P ;

Lau, JS ;

Wong, KF ;

Kwong, YL .

LEUKEMIA, 2005, 19 (12) :2241-2246

[9]

Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias [J].

Chim, CS ;

Wong, ASY ;

Kwong, YL .

ANNALS OF HEMATOLOGY, 2004, 83 (08) :527-532

[10]

SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway [J].

Chim, CS ;

Fung, TK ;

Cheung, WC ;

Liang, R ;

Kwong, YL .

BLOOD, 2004, 103 (12) :4630-4635

← 1 2 3 4 →